Medical Oncologist, VIC
Jim Whittle is Neuro Oncologist at the Peter MacCallum Cancer Centre (PeterMac) and joint-head of the Brain Cancer Research Laboratory at WEHI. Jim’s research expertise and reputation are built on a deep understanding of basic biology, the development of patient-derived models for drug discovery, and clinical translation. His clinical research focuses on implementing novel Phase 0 (Perioperative) clinical trials as part of a paradigm shift in drug development.
An emerging leader in the field of Neuro Oncology, Jim has an established institutional and national profile, currently serving on the management committee and chairing the Outreach and Education Committee for the Cooperative Group for Neuro Oncology (COGNO), as well as participating in various committees within the Society of Neuro Oncology (SNO). In 2023, Jim was appointed Co-Director of Research Strategy at the Brain Cancer Centre (Melbourne) and sits on the research advisory committee for the Mark Hughes Foundation Centre for Brain Cancer Research.
This information is available to COGNO members.
COGNO recently published its Expert Position Statement on the management of adults with IDH-mutant gliomas in the Asia-Pacific Journal of Clinical Oncology, the first Australian consensus guidance for multidisciplinary teams navigating treatment…
Brought to you by the COGNO Education Committee. 'From Idea to Trial Concept' is the first in a new series of COGNO skills development workshops, designed to build research capacity across the…
Hear expert insights with an Australian lens Join us for an exclusive virtual post-conference update of the latest breakthroughs in brain cancer research and treatment from WFNOS / SNO 2025. This insightful…
